New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Dynavax Technologies Corporation
DVAX
Shape
US Flag

NASDAQ

EPS improving

EPS improving

2B

Drug Manufacturers - Specialty & Generic

13.50USD
Shape-0.16 ( -1.17%)
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

49%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

10%

Quote Panel

Shape
Updated November 13, 2024
1W 12.31 % 1M 29.06 % 3M 19.79 % 1Y -2.17 %

Key Metrics

Shape
  • Market Cap

    1.77B


  • Shares Outstanding

    131.46M


  • Share in Float

    130.82M


  • Dividende

    0


  • Earning Date

    No Data


  • Price Target

    13.5


  • Average Volume

    2.10M


  • Beta

    1.342


  • Range

    9.74-15.01


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.dynavax.com


  • Sector

    Healthcare


Fundamentals

Shape

102.55x

P/E Ratio

6.92x

P/S Ratio

2.63x

P/B Ratio

0.4

Debt/Equity

7.9%

Net Margin

$0.1

EPS

How DVAX compares to sector?

P/E Ratio

Relative Strength

Shape

DVAX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$332M

Shape318%

2025-Revenue

$0.25

Shape95%

2025-EPS

$78M

Shape-872%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

JMP Securities

initialise

Previous: Not converted

2022-09-27

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

-15%

0.45
vs 0.53

Q1.23

arrow
arrow

N/A

-0.19
vs 0.22

Q2.23

arrow
arrow

-97%

0.03
vs 0.87

Q3.23

arrow
arrow

-77%

0.1
vs 0.43

Q4.23

arrow
arrow

-100%

0
vs 0.45

Q1.24

arrow
arrow

N/A

-0.07
vs -0.19

Q2.24

arrow
arrow

+167%

0.08
vs 0.03

Q3.24

arrow
arrow

+20%

0.12
vs 0.1

Q4.24

arrow
arrow

+2217%

0.04
vs 0

Q1.25

arrow
arrow

+133%

0.02
vs -0.07

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

-5%

184.5M  vs 195.1M

Q1.23

arrow
arrow

-59%

46.9M  vs 114M

Q2.23

arrow
arrow

-77%

60.2M  vs 256.5M

Q3.23

arrow
arrow

-59%

69.5M  vs 167.7M

Q4.23

arrow
arrow

-70%

55.6M  vs 184.5M

Q1.24

arrow
arrow

+8%

50.8M  vs 46.9M

Q2.24

arrow
arrow

+22%

73.8M  vs 60.2M

Q3.24

arrow
arrow

+14%

79.3M  vs 69.5M

Q4.24

arrow
arrow

+29%

71.7M  vs 55.6M

Q1.25

arrow
arrow

+37%

69.8M  vs 50.8M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

+12%

0.12
vs 0.13

Q1.23

arrow
arrow

-4%

-0.04
vs 0.12

Q2.23

arrow
arrow

+1%

0.01
vs -0.04

Q3.23

arrow
arrow

+2%

0.02
vs 0.01

Q4.23

arrow
arrow

+0%

0
vs 0.02

Q1.24

arrow
arrow

-1%

-0.01
vs 0

Q2.24

arrow
arrow

+2%

0.02
vs -0.01

Q3.24

arrow
arrow

+3%

0.03
vs 0.02

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

244

244
vs 220

11%

Q4.22

arrow
arrow

240

240
vs 244

-2%

Q1.23

arrow
arrow

215

215
vs 240

-10%

Q2.23

arrow
arrow

217

217
vs 215

1%

Q3.23

arrow
arrow

230

230
vs 217

6%

Q4.23

arrow
arrow

246

246
vs 230

7%

Q1.24

arrow
arrow

256

256
vs 246

4%

Q2.24

arrow
arrow

243

243
vs 256

-5%

Earnings Growth

Latest News